FDA Commissioner Robert Califf discussed healthcare AI at the HLTH conference, stating the challenge of balancing regulation with creativity. The FDA can’t monitor all AI developments and providers struggle with ongoing validation. Califf worries that AI may worsen health disparities by segregating profitable and unprofitable patients. He notes the U.S. healthcare system’s primary care deficiencies and advocates for technology to address fundamental health needs. Califf suggests improving data sharing and interoperability in healthcare to address ongoing validation issues. He emphasizes the potential of technology to improve public health if focused on essential healthcare needs.
Source link
4 Things That Worry FDA Commissioner Robert Califf
